INS and type 2 diabetes mellitus: miR-130a, miR-130b, and miR-152 are found to have overexpression in T2D patient islets, where they each reduced the level of the common target pyruvate dehydrogenase E1 alpha 1 subunit (PDHA1), thereby reducing intracellular ATP and insulin secretion (27).